GPT Healthcare Q1 FY27 Income Up 18% to ₹128 Crore, PAT Rises 65.7%
GPT Healthcare reported Q1 FY27 unaudited results with Total Income up 18% to ₹128 crore and PAT rising 65.7% to ₹12.7 crore. EBITDA increased 38.5% to ₹26.2 crore. The company is expanding its network, with a seventh hospital expected to increase capacity to over 1,000 beds.
The significant increase in financial metrics and positive operational highlights, coupled with future expansion plans, are likely to have a substantial positive impact on investor sentiment and the company's valuation.
The company reported strong year-on-year growth in revenue, EBITDA, and profit after tax, along with operational improvements and strategic expansion plans.
GPT Healthcare Limited (GPT) has announced its unaudited financial results for the first quarter of the financial year 2027, ended June 30, 2026. The company reported a Total Income of ₹128 crore, marking an 18.0% year-on-year growth from ₹108.7 crore in Q1 FY26. EBITDA for the quarter stood at ₹26.2 crore, an increase of 38.5% from ₹18.9 crore in the same period last year. Profit After Tax (PAT) saw a significant surge of 65.7%, reaching ₹12.7 crore in Q1 FY27, compared to ₹7.7 crore in Q1 FY26. The PAT margin improved to 9.9% from 7.1% year-on-year.
Operationally, GPT Healthcare maintained an Average Revenue Per Operating Bed (ARPOB) of ₹42,350. Occupancy rates improved to 58.07% (excluding the newly opened Raipur facility), and 45.5% including it. Several of its ILS Hospitals achieved significant milestones: ILS Dum Dum completed over 700 renal transplants, ILS Howrah launched a Robotic Knee Surgery programme, ILS Agartala delivered over 700 radiation therapy procedures, and ILS Salt Lake surpassed 800 robotic surgeries. ILS Raipur received its liver transplant license and is projected to achieve breakeven by Q3 FY27, while the Jamshedpur hospital is on track for completion by Q4 FY27.
Commenting on the performance, GPT Healthcare Chairman, Dr. Om Tantia, highlighted the company's focus on long-term growth strategies, including improving occupancy in mature hospitals, ramping up newer facilities, and expanding high-value specialties. The company is also finalizing its seventh hospital, which will increase its total bed capacity to over 1,000. These initiatives, supported by standardized clinical governance and operational efficiencies, are expected to drive sustainable returns while maintaining a net-debt-free position.
What to do with a filing like this
GPT Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by GPT Healthcare Limited. Read the original for the full detail.